AFT Pharmaceuticals Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Hartley Atkinson
Chief executive officer
NZ$931.2k
Total compensation
CEO salary percentage | 65.1% |
CEO tenure | 26.6yrs |
CEO ownership | 68.7% |
Management average tenure | no data |
Board average tenure | 6.1yrs |
Recent management updates
Recent updates
Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?
May 22Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?
Oct 17Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?
May 23Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?
Dec 01We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise
Jul 30With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For
Jun 02Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?
Mar 20A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation
Feb 13Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 23Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?
Jan 02Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?
Dec 12AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 21CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2023 | n/a | n/a | NZ$11m |
Jun 30 2023 | n/a | n/a | NZ$11m |
Mar 31 2023 | NZ$931k | NZ$606k | NZ$11m |
Dec 31 2022 | n/a | n/a | NZ$14m |
Sep 30 2022 | n/a | n/a | NZ$17m |
Jun 30 2022 | n/a | n/a | NZ$18m |
Mar 31 2022 | NZ$840k | NZ$578k | NZ$20m |
Dec 31 2021 | n/a | n/a | NZ$15m |
Sep 30 2021 | n/a | n/a | NZ$11m |
Jun 30 2021 | n/a | n/a | NZ$9m |
Mar 31 2021 | NZ$701k | NZ$506k | NZ$8m |
Dec 31 2020 | n/a | n/a | NZ$5m |
Sep 30 2020 | n/a | n/a | NZ$3m |
Jun 30 2020 | n/a | n/a | NZ$7m |
Mar 31 2020 | NZ$592k | NZ$443k | NZ$12m |
Dec 31 2019 | n/a | n/a | NZ$11m |
Sep 30 2019 | n/a | n/a | NZ$11m |
Jun 30 2019 | n/a | n/a | NZ$4m |
Mar 31 2019 | NZ$556k | NZ$431k | -NZ$3m |
Dec 31 2018 | n/a | n/a | -NZ$7m |
Sep 30 2018 | n/a | n/a | -NZ$11m |
Jun 30 2018 | n/a | n/a | -NZ$12m |
Mar 31 2018 | NZ$514k | NZ$429k | -NZ$14m |
Compensation vs Market: Hartley's total compensation ($USD552.36K) is about average for companies of similar size in the NZ market ($USD574.88K).
Compensation vs Earnings: Hartley's compensation has been consistent with company performance over the past year.
CEO
Hartley Atkinson
26.6yrs
Tenure
NZ$931,219
Compensation
Dr. Hartley Atkinson, M.Pharm (Dist), PhD, is Co-Founder of AFT Pharmaceuticals Limited in 1997. Dr. Atkinson is Chief Executive Officer of AFT Pharmaceuticals Limited since September 04, 1997 and also ser...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 26.6yrs | NZ$931.22k | 68.69% NZ$ 221.1m | |
Co-Founder | 11.6yrs | NZ$160.92k | no data | |
Independent Non-Executive Director | 3.3yrs | NZ$144.81k | no data | |
Independent Chairman | 8.8yrs | NZ$137.50k | 0.17% NZ$ 548.8k | |
Independent Non-Executive Director | less than a year | no data | no data | |
Independent Non-Executive Director | 3.4yrs | NZ$75.00k | no data |
6.1yrs
Average Tenure
Experienced Board: AFT's board of directors are considered experienced (6.1 years average tenure).